Skip to main content
. 2020 Jun 13;33(6):1321–1332. doi: 10.1007/s40620-020-00775-4

Table 1.

Demographic data of donors

Age [mean(SD); median (range)] Gender
Lymphoma = 38 (20) 37.7 (23.5); 30.5 (7–71)

M = 11 (29)

F = 6 (16)

NA = 21 (55)

Renal cell carcinoma = 37 (20) 54.8 (10.2); 56.5 (32–73)

M = 19 (51)

F = 9 (24)

NA = 9 (24)

Melanoma = 30 (16) 54.4 (12.3); 51.5 (42–73)

M = 5 (17)

F = 7 (23)

NA = 18 (60)

NSCLC = 12 (6) 47.7 (12); 51 (29–63)

M = 5 (42)

F = 5 (42)

NA = 2 (16)

Neuroendocrine = 8 (4) 59 (6.3); 59 (51–67)

M = 5 (63)

F = 2 (25)

NA = 1 (12)

Choriocarcinoma = 7 (4) 33.1 (7.3); 30 (26–47) F = 7 (100)
Glioblastoma = 3 (2) 37 (7.1); 37 (32–42)

M = 2 (67)

NA = 1 (33)

Breast cancer = 4 (2) 45.3 (6.8); 43 (40–53) F = 4 (100)
Leukemia = 7 (4) 51.5 (25.2); 47.5 (19–81)

M = 1 (14)

F = 4 (57)

NA = 2 (29)

Other = 41 (22) 49.4 (17.6); 53 (0.2–73)

M = 21 (51)

F = 14 (34)

NA = 6 (15)

Total = 187 (100) 48.3 (17.2); 51.5 (0.2–81)

M = 69 (37)

F = 58 (31)

NA = 60 (32)

Apart from age, numbers represent absolute values with percentages in parentheses

F female, M male, NA not available, NSCLC non-small cell lung cancer, SD standard deviation